Active Ingredient: RIFAXIMIN
Proprietary Name: XIFAXAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 200MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021361
Product Number: 001
Approval Date: May 25, 2004
Applicant Holder Full Name: SALIX PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information